IAIM
ICPT

International Assets Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

International Assets Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$2K – 2053
2021
Q1 		$2K Hold
100
– – ﹤0.01% 2060
2020
Q4 		$2K Buy
+100
New +$3.31K ﹤0.01% 1937

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

International Assets Investment Management's ICPT Position: Q2 2021 in Review

International Assets Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 100 shares — an estimated $2K sold.

International Assets Investment Management first reported a position in ICPT in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

  • International Assets Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 100 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $2K.
  • International Assets Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q1 2021.
  • 129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.